Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
AC5 Advanced Wound System is a proprietary synthetic peptide that self-assembles into a wound matrix upon application. This matrix functions as a physical-mechanical barrier, mitigating contamination, modulating inflammation, and providing a scaffold for cell proliferation and growth. It is designed to promote hemostasis and facilitate the healing of various wounds, including hard-to-heal wounds and diabetic foot ulcers. The system has been evaluated for its safety and performance in controlling bleeding following skin lesion excisions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on AC5 Advanced Wound System.